Hormone replacement therapy with L-thyroxine promotes working memory and concentration in thyroidectomized female patients after differentiated thyroid carcinoma

Int J Psychiatry Med. 2020 Mar;55(2):114-122. doi: 10.1177/0091217419885751. Epub 2019 Nov 5.

Abstract

Objective: It is well established that long-term hypothyroidism is associated with cognitive deficits. Based on recent literature, we hypothesized that pharmacologically induced euthyroidism would lead to improved cognitive performance compared to a hypothyroid state.

Methods: We analyzed data from 14 nondepressed thyroidectomized female patients after differentiated thyroid carcinoma during hypothyroidism (due to a four-week withdrawal of thyroid hormone, T1) and euthyroidism brought about by substitution with L-thyroxine (T2). At both measurement points, patients completed a cognitive test battery as our dependent measure and Beck’s Depression Inventory to control depressive states.

Results: A Wilcoxon signed-rank tests revealed a significant improvement in the Rey–Osterrieth complex figure test (cognitive reproduction), Z = −3.183, p = 0.001, and the D2 concentration score, Z = −1.992, p = 0.046 in euthyroidism compared to hypothyroidism.

Conclusions: Our results confirm that hormone replacement therapy with L-thyroxine promotes cognitive reproduction and concentration in thyroidectomized female patients after differentiated thyroid carcinoma.

Keywords: cognitive function; depression; hypothyroidism; levothyroxine therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Attention / drug effects*
  • Female
  • Hormone Replacement Therapy*
  • Humans
  • Hypothyroidism / drug therapy*
  • Hypothyroidism / etiology
  • Hypothyroidism / psychology
  • Memory, Short-Term / drug effects*
  • Middle Aged
  • Neuropsychological Tests
  • Thyroid Neoplasms / surgery
  • Thyroidectomy
  • Thyroxine / pharmacology
  • Thyroxine / therapeutic use*
  • Young Adult

Substances

  • Thyroxine